메뉴 건너뛰기




Volumn 3, Issue 2, 2013, Pages 102-111

Nanocarriers as Promising Drug Vehicles for the Management of Tuberculosis

Author keywords

Dendrimers; Emulsions; Liposomes; Nanomedicine; Nanoparticles; Nanosuspensions; Nanotechnology; Niosomes; Polylactide co glycolide microparticles (PLG); Tuberculosis

Indexed keywords

INTRACELLULAR PATHOGENS; MICRO-PARTICLES; MYCOBACTERIUM TUBERCULOSIS; NANO-SUSPENSIONS; NIOSOMES; STATE-OF-ART TECHNOLOGY; TECHNOLOGY ADVANCEMENT; TUBERCULOSIS;

EID: 84878026536     PISSN: 21911630     EISSN: 21911649     Source Type: Journal    
DOI: 10.1007/s12668-013-0084-7     Document Type: Article
Times cited : (7)

References (77)
  • 2
    • 0029999550 scopus 로고    scopus 로고
    • The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the centres for disease control and prevention's Pneumococcal Sentinal Surveillance System
    • Butler, J. C., Hofman, J., Cetron, M. S., Elliot, J. A., Arancibia, F., et al. (1996). The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the centres for disease control and prevention's Pneumococcal Sentinal Surveillance System. Journal of Infectious Diseases, 174, 986-993.
    • (1996) Journal of Infectious Diseases , vol.174 , pp. 986-993
    • Butler, J.C.1    Hofman, J.2    Cetron, M.S.3    Elliot, J.A.4    Arancibia, F.5
  • 3
    • 0027531810 scopus 로고
    • Resistance to antimicrobial drugs-a world-wide calamity
    • Kunin, C. M. (1993). Resistance to antimicrobial drugs-a world-wide calamity. Annals of International Medicine, 118, 557-561.
    • (1993) Annals of International Medicine , vol.118 , pp. 557-561
    • Kunin, C.M.1
  • 5
    • 0033581124 scopus 로고    scopus 로고
    • Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project
    • Dye, C., Sheele, S., Dolin, P., Pathania, V., Raviglione, M. C. (1999). Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. Journal of the American Medical Association, 282, 677-686.
    • (1999) Journal of the American Medical Association , vol.282 , pp. 677-686
    • Dye, C.1    Sheele, S.2    Dolin, P.3    Pathania, V.4    Raviglione, M.C.5
  • 6
    • 71049155446 scopus 로고    scopus 로고
    • Emergence of Mycobacteria tuberculosis with extensive resistance to second line drugs worldwide
    • Wright, A. (2006). Emergence of Mycobacteria tuberculosis with extensive resistance to second line drugs worldwide. Journal of the American Medical Association, 295, 2349-2351.
    • (2006) Journal of the American Medical Association , vol.295 , pp. 2349-2351
    • Wright, A.1
  • 9
    • 1242286956 scopus 로고    scopus 로고
    • Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs
    • Prabakaran, D., Singh, P., Jaganathan, K. S., Vyas, S. P. (2004). Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs. Journal of Controlled Release, 95(2), 239-248.
    • (2004) Journal of Controlled Release , vol.95 , Issue.2 , pp. 239-248
    • Prabakaran, D.1    Singh, P.2    Jaganathan, K.S.3    Vyas, S.P.4
  • 10
    • 39149118304 scopus 로고    scopus 로고
    • Advances in lipid nano-dispersions for parenteral drug delivery and targeting
    • Constantinides, P. P., Chaubal, M. V., Shorr, R. (2008). Advances in lipid nano-dispersions for parenteral drug delivery and targeting. Advanced Drug Delivery Reviews, 60, 757-767.
    • (2008) Advanced Drug Delivery Reviews , vol.60 , pp. 757-767
    • Constantinides, P.P.1    Chaubal, M.V.2    Shorr, R.3
  • 11
    • 1542298888 scopus 로고    scopus 로고
    • A nanometer lipid emulsion, lipid nano-sphere (LNS) as a parenteral drug carrier for drug targeting
    • Seki, J., et al. (2004). A nanometer lipid emulsion, lipid nano-sphere (LNS) as a parenteral drug carrier for drug targeting. International Journal of Pharmacology, 273(1-2), 75-83.
    • (2004) International Journal of Pharmacology , vol.273 , Issue.1-2 , pp. 75-83
    • Seki, J.1
  • 12
    • 44649127287 scopus 로고    scopus 로고
    • Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum
    • Singh, S. K., et al. (2008). Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum. Clinical Chim Acta, 394(1-2), 94-98.
    • (2008) Clinical Chim Acta , vol.394 , Issue.1-2 , pp. 94-98
    • Singh, S.K.1
  • 13
    • 56749107618 scopus 로고    scopus 로고
    • Potential of nano-emulsions for intravenous delivery
    • Ahmed, M., Ramadan, W., Rambhu, D., Shakeel, F. (2008). Potential of nano-emulsions for intravenous delivery. Pharmazie, 63, 806-811.
    • (2008) Pharmazie , vol.63 , pp. 806-811
    • Ahmed, M.1    Ramadan, W.2    Rambhu, D.3    Shakeel, F.4
  • 16
  • 17
    • 64649086799 scopus 로고    scopus 로고
    • Solid state amorphization of pharmaceuticals
    • Williart, J. F., & Descamps, M. (2008). Solid state amorphization of pharmaceuticals. Molecular Pharmacology, 5, 905-920.
    • (2008) Molecular Pharmacology , vol.5 , pp. 905-920
    • Williart, J.F.1    Descamps, M.2
  • 18
    • 34548049483 scopus 로고    scopus 로고
    • Nano-sizing oral formulation development and biopharmaceutical evaluation
    • Kesisoglou, F., Panmai, S., Wu, Y. (2007). Nano-sizing oral formulation development and biopharmaceutical evaluation. Advanced Drug Delivery Reviews, 59, 631-644.
    • (2007) Advanced Drug Delivery Reviews , vol.59 , pp. 631-644
    • Kesisoglou, F.1    Panmai, S.2    Wu, Y.3
  • 19
    • 0033965872 scopus 로고    scopus 로고
    • Preparation of a clofazimine nano-suspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection
    • Peters, K., et al. (2000). Preparation of a clofazimine nano-suspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. Journal of Antimicrobial Chemotherapy, 45, 77-83.
    • (2000) Journal of Antimicrobial Chemotherapy , vol.45 , pp. 77-83
    • Peters, K.1
  • 20
    • 0037190027 scopus 로고    scopus 로고
    • Rifampicin microparticle production by supercritical antisolvent precipitation
    • Reverchon, E., DeMarco, I., DellaPorta, G. (2002). Rifampicin microparticle production by supercritical antisolvent precipitation. International Journal of Pharmacology, 243, 83-91.
    • (2002) International Journal of Pharmacology , vol.243 , pp. 83-91
    • Reverchon, E.1    DeMarco, I.2    DellaPorta, G.3
  • 21
    • 0037678925 scopus 로고    scopus 로고
    • Micronization of antibiotics by supercritical assisted atomization
    • Reverchon, E., & DellaPorta, G. (2003). Micronization of antibiotics by supercritical assisted atomization. Journal of Supercritical Fluids, 26, 243-252.
    • (2003) Journal of Supercritical Fluids , vol.26 , pp. 243-252
    • Reverchon, E.1    DellaPorta, G.2
  • 22
    • 84900141096 scopus 로고    scopus 로고
    • Niosomes as nanocarrier systems
    • M. R. Moza (Ed.), the Netherlands: Springer
    • Sahin, N. O. (2007). Niosomes as nanocarrier systems. In M. R. Moza (Ed.), Nanomaterials and nanosystems for biomedical applications (pp. 67-81). the Netherlands: Springer.
    • (2007) Nanomaterials and Nanosystems for Biomedical Applications , pp. 67-81
    • Sahin, N.O.1
  • 23
    • 0029052419 scopus 로고
    • Preparation and characterization of niosomes containing rifampicin for lung targeting
    • Jain, C. P., & Vyas, S. P. (1995). Preparation and characterization of niosomes containing rifampicin for lung targeting. Journal of Microencapsulation, 12, 401-407.
    • (1995) Journal of Microencapsulation , vol.12 , pp. 401-407
    • Jain, C.P.1    Vyas, S.P.2
  • 24
    • 33846162000 scopus 로고    scopus 로고
    • Niosomal system for delivery of rifampicin to lymphatics
    • Jain, C. P., Vyas, S. P., Dixit, V. K. (2006). Niosomal system for delivery of rifampicin to lymphatics. Indian Journal of Pharmacology, 68, 575-578.
    • (2006) Indian Journal of Pharmacology , vol.68 , pp. 575-578
    • Jain, C.P.1    Vyas, S.P.2    Dixit, V.K.3
  • 25
    • 1942505838 scopus 로고    scopus 로고
    • Lung accumulation of niosome entrapped rifampicin following intravenous and intratracheal administration in the rat
    • Mullaicharam, A. R., & Murthy, R. S. R. (2004). Lung accumulation of niosome entrapped rifampicin following intravenous and intratracheal administration in the rat. Journal of Drug Delivery Science and Technology, 14, 99-104.
    • (2004) Journal of Drug Delivery Science and Technology , vol.14 , pp. 99-104
    • Mullaicharam, A.R.1    Murthy, R.S.R.2
  • 27
    • 0035186635 scopus 로고    scopus 로고
    • DNA vaccines-future strategies and relevance against intracellular pathogens
    • Sharma, A. K., & Khuller, G. K. (2001). DNA vaccines-future strategies and relevance against intracellular pathogens. Immunology & Cell Biology, 79(6), 537-546.
    • (2001) Immunology & Cell Biology , vol.79 , Issue.6 , pp. 537-546
    • Sharma, A.K.1    Khuller, G.K.2
  • 28
    • 15544362279 scopus 로고    scopus 로고
    • Polymeric particulates to improve oral bioavailability of peptide drugs
    • Delie, F., & Blanco-Prieto, M. J. (2005). Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules, 10, 65-80.
    • (2005) Molecules , vol.10 , pp. 65-80
    • Delie, F.1    Blanco-Prieto, M.J.2
  • 29
    • 0032857703 scopus 로고    scopus 로고
    • Adjuvant modulation of T-cell reactivity to 30 kDa secretory protein of Mycobacterium tuberculosis H37Rv and its protective efficacy against experimental tuberculosis
    • Sharma, A. K., Verma, I., Tewari, R., Khuller, G. K. (1999). Adjuvant modulation of T-cell reactivity to 30 kDa secretory protein of Mycobacterium tuberculosis H37Rv and its protective efficacy against experimental tuberculosis. Journal of Medical Microbiology, 48, 757-763.
    • (1999) Journal of Medical Microbiology , vol.48 , pp. 757-763
    • Sharma, A.K.1    Verma, I.2    Tewari, R.3    Khuller, G.K.4
  • 30
    • 0347519282 scopus 로고    scopus 로고
    • Poly(DL-lactide-co-glycolide nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis
    • Pandey, R., Sharma, A., Zahoor, A., Sharma, S., Khuller, G. K., Prasad, B. (2003). Poly(DL-lactide-co-glycolide nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis. Journal of Antimicrobial Chemotherapy, 52, 981-986.
    • (2003) Journal of Antimicrobial Chemotherapy , vol.52 , pp. 981-986
    • Pandey, R.1    Sharma, A.2    Zahoor, A.3    Sharma, S.4    Khuller, G.K.5    Prasad, B.6
  • 31
    • 77957120419 scopus 로고    scopus 로고
    • In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems
    • Semete B., et al. (2010) In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine, 6, 662-671.
    • (2010) Nanomedicine: Nanotechnology, Biology and Medicine , vol.6 , pp. 662-671
    • Semete, B.1
  • 32
    • 33751512735 scopus 로고    scopus 로고
    • Polymeric micelles for drug-delivery
    • Croy, S. R., & Kwon, G. S. (2006). Polymeric micelles for drug-delivery. Current Pharmaceutical Design, 12, 4669-4684.
    • (2006) Current Pharmaceutical Design , vol.12 , pp. 4669-4684
    • Croy, S.R.1    Kwon, G.S.2
  • 33
    • 80053364035 scopus 로고    scopus 로고
    • Recent advances in materials for extended-release antibiotic delivery system
    • doi:10.1038/ja.2011.58
    • Gao, P., Nie, X., Zou, M., Shi, Y., Cheng, G. (2011). Recent advances in materials for extended-release antibiotic delivery system. Journal of Antibiotics (Tokyo). doi: 10. 1038/ja. 2011. 58.
    • (2011) Journal of Antibiotics (Tokyo)
    • Gao, P.1    Nie, X.2    Zou, M.3    Shi, Y.4    Cheng, G.5
  • 34
    • 36048983390 scopus 로고    scopus 로고
    • Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis
    • Kisich, K. O., et al. (2007). Encapsulation of moxifloxacin within poly(butyl cyanoacrylate) nanoparticles enhances efficacy against intracellular Mycobacterium tuberculosis. International Journal of Pharmacology, 345, 154-162.
    • (2007) International Journal of Pharmacology , vol.345 , pp. 154-162
    • Kisich, K.O.1
  • 35
    • 54049146207 scopus 로고    scopus 로고
    • Development of nanosomal formulation of moxifloxacin based on poly(butyl-2-cyanoacrylate)
    • Shipulo, E., et al. (2008). Development of nanosomal formulation of moxifloxacin based on poly(butyl-2-cyanoacrylate). Pharmaceutical Chemistry Journal, 42, 145-149.
    • (2008) Pharmaceutical Chemistry Journal , vol.42 , pp. 145-149
    • Shipulo, E.1
  • 36
    • 0034983545 scopus 로고    scopus 로고
    • Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in poly (DL-lactide-co-glycolide) microparticles
    • Dutt, M., & Khuller, G. K. (2001). Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in poly (DL-lactide-co-glycolide) microparticles. Journal of Antimicrobial Chemotherapy, 47(6), 829-835.
    • (2001) Journal of Antimicrobial Chemotherapy , vol.47 , Issue.6 , pp. 829-835
    • Dutt, M.1    Khuller, G.K.2
  • 37
    • 0037018964 scopus 로고    scopus 로고
    • Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s)
    • Ain, Q., Sharma, S., Garg, S. K., Khuller, G. K. (2002). Role of poly [DL-lactide-co-glycolide] in development of a sustained oral delivery system for antitubercular drug(s). International Journal of Pharmacology, 239(1-2), 37-46.
    • (2002) International Journal of Pharmacology , vol.239 , Issue.1-2 , pp. 37-46
    • Ain, Q.1    Sharma, S.2    Garg, S.K.3    Khuller, G.K.4
  • 39
    • 0028152507 scopus 로고
    • Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer
    • Kailasam, S., Daneluzzi, D., Gangadharam, P. R. (1994). Maintenance of therapeutically active levels of isoniazid for prolonged periods in rabbits after a single implant of biodegradable polymer. Tubercle and Lung Disease, 75(5), 361-365.
    • (1994) Tubercle and Lung Disease , vol.75 , Issue.5 , pp. 361-365
    • Kailasam, S.1    Daneluzzi, D.2    Gangadharam, P.R.3
  • 40
    • 0347418154 scopus 로고    scopus 로고
    • Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages
    • Vyas, S. P., Kannan, M. E., Jain, S., Mishra, V., Singh, P. (2004). Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. International Journal of Pharmacology, 269(1), 37-49.
    • (2004) International Journal of Pharmacology , vol.269 , Issue.1 , pp. 37-49
    • Vyas, S.P.1    Kannan, M.E.2    Jain, S.3    Mishra, V.4    Singh, P.5
  • 41
    • 1942453805 scopus 로고    scopus 로고
    • Solid lipid nanoparticles for parenteral drug delivery
    • Wissing, S. A., Kayser, O., Muller, R. H. (2004). Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews, 56(9), 1257-1272.
    • (2004) Advanced Drug Delivery Reviews , vol.56 , Issue.9 , pp. 1257-1272
    • Wissing, S.A.1    Kayser, O.2    Muller, R.H.3
  • 42
  • 43
    • 57849090928 scopus 로고    scopus 로고
    • Polymeric micelle composed of PLA and chitosan as a drug carrier
    • Yan, W., Li, M., Gao, H. (2009). Polymeric micelle composed of PLA and chitosan as a drug carrier. Journal of Polymer Research, 16, 11-18.
    • (2009) Journal of Polymer Research , vol.16 , pp. 11-18
    • Yan, W.1    Li, M.2    Gao, H.3
  • 44
    • 0034952920 scopus 로고    scopus 로고
    • Potential tuberculostatic: micelle-forming copolymer poly(ethylene glycol) poly(aspartic acid) prodrug with isoniazid
    • Silva, M., et al. (2001). Potential tuberculostatic: micelle-forming copolymer poly(ethylene glycol) poly(aspartic acid) prodrug with isoniazid. Arch Pharma Med Chem, 334, 189-193.
    • (2001) Arch Pharma Med Chem , vol.334 , pp. 189-193
    • Silva, M.1
  • 45
    • 33745531638 scopus 로고    scopus 로고
    • Potential tubercular anti TB agent: micelle forming pyrazinamide prodrug
    • Silva, M., et al. (2006). Potential tubercular anti TB agent: micelle forming pyrazinamide prodrug. Arch Pharma Chem, 339, 283-290.
    • (2006) Arch Pharma Chem , vol.339 , pp. 283-290
    • Silva, M.1
  • 46
    • 53249112240 scopus 로고    scopus 로고
    • Preparation of polymeric micelles for use as carriers of tuberculostatic drugs
    • Silva, M., et al. (2007). Preparation of polymeric micelles for use as carriers of tuberculostatic drugs. Tropical Journal of Pharmaceutical Research, 6, 815-824.
    • (2007) Tropical Journal of Pharmaceutical Research , vol.6 , pp. 815-824
    • Silva, M.1
  • 47
    • 33750127627 scopus 로고    scopus 로고
    • Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers
    • Kumar, P. V., Asthana, A., Dutta, T., Jain, N. K. (2006). Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. Journal of Drug Targeting, 14(8), 546-556.
    • (2006) Journal of Drug Targeting , vol.14 , Issue.8 , pp. 546-556
    • Kumar, P.V.1    Asthana, A.2    Dutta, T.3    Jain, N.K.4
  • 48
    • 33846115676 scopus 로고    scopus 로고
    • PEGylated dendritic architecture for the development of a prolonged drug delivery system for an antitubercular drug
    • Kumar, P. V., Agashe, H., Dutta, T., Jain, N. K. (2007). PEGylated dendritic architecture for the development of a prolonged drug delivery system for an antitubercular drug. Current Drug Delivery, 4(1), 11-19.
    • (2007) Current Drug Delivery , vol.4 , Issue.1 , pp. 11-19
    • Kumar, P.V.1    Agashe, H.2    Dutta, T.3    Jain, N.K.4
  • 49
    • 33750486186 scopus 로고    scopus 로고
    • Physicochemical characterization of a-cyclodextrin and hydroxyethyl a-cyclodextrin complexes of rifampicin
    • Rao, B. P., Suresh, S., Narendra, C., Balasangameshwer. (2006). Physicochemical characterization of a-cyclodextrin and hydroxyethyl a-cyclodextrin complexes of rifampicin. Ars Pharmaceutica, 47, 37-59.
    • (2006) Ars Pharmaceutica , vol.47 , pp. 37-59
    • Rao, B.P.1    Suresh, S.2    Narendra, C.3    Balasangameshwer4
  • 50
    • 0025282170 scopus 로고
    • Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice
    • Klemens, S. P., Cynamon, M. H., Swenson, C. E., Ginsberg, R. S. (1990). Liposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige mice. Antimicrobial Agents and Chemotherapy, 34(6), 967-970.
    • (1990) Antimicrobial Agents and Chemotherapy , vol.34 , Issue.6 , pp. 967-970
    • Klemens, S.P.1    Cynamon, M.H.2    Swenson, C.E.3    Ginsberg, R.S.4
  • 51
    • 0029129973 scopus 로고
    • Formulation and efficacy of liposome encapsulated antibiotics for the therapy of intracellular Mycobacterium avium infection
    • Oh, Y. K., Nix, D. E., Straubinger, R. M. (1995). Formulation and efficacy of liposome encapsulated antibiotics for the therapy of intracellular Mycobacterium avium infection. Antimicrobial Agents and Chemotherapy, 39, 2104-2111.
    • (1995) Antimicrobial Agents and Chemotherapy , vol.39 , pp. 2104-2111
    • Oh, Y.K.1    Nix, D.E.2    Straubinger, R.M.3
  • 52
    • 0031943679 scopus 로고    scopus 로고
    • Rationale for and efficacy of prolonged interval treatment using liposome encapsulated amikacin in experimental Mycobacterium avium infection
    • Leitzke, S., et al. (1998). Rationale for and efficacy of prolonged interval treatment using liposome encapsulated amikacin in experimental Mycobacterium avium infection. Antimicrobial Agents and Chemotherapy, 42, 459-461.
    • (1998) Antimicrobial Agents and Chemotherapy , vol.42 , pp. 459-461
    • Leitzke, S.1
  • 53
    • 0030918970 scopus 로고    scopus 로고
    • Therapeutic efficacy of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice
    • Deol, P., Khuller, G. K., Joshi, K. (1997). Therapeutic efficacy of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice. Antimicrobial Agents and Chemotherapy, 41, 1211.
    • (1997) Antimicrobial Agents and Chemotherapy , vol.41 , pp. 1211
    • Deol, P.1    Khuller, G.K.2    Joshi, K.3
  • 54
    • 18444392735 scopus 로고    scopus 로고
    • Birth of new molecular architecture: dendrimers as quantized building blocks for nano-scale synthetic polymer chemistry
    • Tomalia, D. A. (2005). Birth of new molecular architecture: dendrimers as quantized building blocks for nano-scale synthetic polymer chemistry. Progress in Polymer Science, 30, 294-324.
    • (2005) Progress in Polymer Science , vol.30 , pp. 294-324
    • Tomalia, D.A.1
  • 55
    • 11144356026 scopus 로고    scopus 로고
    • Cyclodextrins as a potential carrier in drug nebulization
    • Evrard, B., et al. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96, 403-410.
    • (2004) Journal of Controlled Release , vol.96 , pp. 403-410
    • Evrard, B.1
  • 56
    • 61949478182 scopus 로고    scopus 로고
    • Bifunctional dendrimers: from robust synthesis and accelerated one-pot postfunctionalization strategy to potential applications
    • Antoni, P., et al. (2009). Bifunctional dendrimers: from robust synthesis and accelerated one-pot postfunctionalization strategy to potential applications. Int. Ed. Engl., 48(12), 2126-2130.
    • (2009) Int. Ed. Engl. , vol.48 , Issue.12 , pp. 2126-2130
    • Antoni, P.1
  • 57
    • 0034595669 scopus 로고    scopus 로고
    • Toward chiral polyhydroxylated dendrimers. Preparation and chiroptical properties
    • McElhanon, J. R., & McGrath, D. V. (2000). Toward chiral polyhydroxylated dendrimers. Preparation and chiroptical properties. Journal of Organic Chemistry, 65(11), 3525-3529.
    • (2000) Journal of Organic Chemistry , vol.65 , Issue.11 , pp. 3525-3529
    • McElhanon, J.R.1    McGrath, D.V.2
  • 58
    • 23744502732 scopus 로고    scopus 로고
    • Incorporation of functional guest molecules into an internally functionalizable dendrimer through olefin metathesis
    • Liang, C. O., & Fréchet, J. M. J. (2005). Incorporation of functional guest molecules into an internally functionalizable dendrimer through olefin metathesis. Macromolecules, 38(15), 6276-6284.
    • (2005) Macromolecules , vol.38 , Issue.15 , pp. 6276-6284
    • Liang, C.O.1    Fréchet, J.M.J.2
  • 59
    • 37649026093 scopus 로고    scopus 로고
    • Dendritic encapsulation of function: applying nature's site isolation principle from biomimetics to materials science
    • Hecht, S., & Fréchet, J. M. J. (2001). Dendritic encapsulation of function: applying nature's site isolation principle from biomimetics to materials science. Angewandte Chemie International Edition, 40(1), 74-91.
    • (2001) Angewandte Chemie International Edition , vol.40 , Issue.1 , pp. 74-91
    • Hecht, S.1    Fréchet, J.M.J.2
  • 60
    • 0028218595 scopus 로고
    • Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy
    • Frechet, J. M. J. (1994). Functional polymers and dendrimers: reactivity, molecular architecture, and interfacial energy. Science, 263(5154), 1710-1715.
    • (1994) Science , vol.263 , Issue.5154 , pp. 1710-1715
    • Frechet, J.M.J.1
  • 62
    • 33847174124 scopus 로고    scopus 로고
    • Targeting potential and anti HIV activity of mannosylated fifth generation poly (propyleneimine) dendrimers
    • Dutta, T., & Jain, N. K. (2007). Targeting potential and anti HIV activity of mannosylated fifth generation poly (propyleneimine) dendrimers. Biochimica et Biophysica Acta, 1770, 681-686.
    • (2007) Biochimica Et Biophysica Acta , vol.1770 , pp. 681-686
    • Dutta, T.1    Jain, N.K.2
  • 63
    • 33847116733 scopus 로고    scopus 로고
    • Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro
    • Dutta, T., et al. (2007). Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. Journal of Drug Targeting, 15(1), 84-96.
    • (2007) Journal of Drug Targeting , vol.15 , Issue.1 , pp. 84-96
    • Dutta, T.1
  • 64
    • 44349124455 scopus 로고    scopus 로고
    • Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro
    • Dutta, T., Garg, T., Jain, N. K. (2008). Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro. European Journal of Pharmaceutical Sciences, 34(2-3), 181-189.
    • (2008) European Journal of Pharmaceutical Sciences , vol.34 , Issue.2-3 , pp. 181-189
    • Dutta, T.1    Garg, T.2    Jain, N.K.3
  • 65
    • 0033119135 scopus 로고    scopus 로고
    • Dendrimers: from design to application-a progress report
    • Fischer, M., & Vogtle, F. (1999). Dendrimers: from design to application-a progress report. Angewandte Chemie International Edition, 38(7), 884-905.
    • (1999) Angewandte Chemie International Edition , vol.38 , Issue.7 , pp. 884-905
    • Fischer, M.1    Vogtle, F.2
  • 68
    • 0347360189 scopus 로고    scopus 로고
    • Formulation and characterization of spray dried powders containing nano-particles for aerosol delivery to the lung
    • Sham, J. O., Zhang, Y., Finlay, W. H., Roa, W. H., Lobenberg, R. (2004). Formulation and characterization of spray dried powders containing nano-particles for aerosol delivery to the lung. International Journal of Pharmacology, 269, 457-467.
    • (2004) International Journal of Pharmacology , vol.269 , pp. 457-467
    • Sham, J.O.1    Zhang, Y.2    Finlay, W.H.3    Roa, W.H.4    Lobenberg, R.5
  • 69
    • 6344277290 scopus 로고    scopus 로고
    • Lectin functionalized poly(lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis
    • Sharma, A., Sharma, S., Khuller, G. K. (2004). Lectin functionalized poly(lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis. Journal of Antimicrobial Agents and Chemotherapy, 54, 761-766.
    • (2004) Journal of Antimicrobial Agents and Chemotherapy , vol.54 , pp. 761-766
    • Sharma, A.1    Sharma, S.2    Khuller, G.K.3
  • 70
    • 3543139595 scopus 로고    scopus 로고
    • Subcutaneous nano-particle based antitubercular chemotherapy in an experimental model
    • Pandey, R., & Khuller, G. K. (2004). Subcutaneous nano-particle based antitubercular chemotherapy in an experimental model. Journal of Antimicrobial Agents and Chemotherapy, 54, 266-268.
    • (2004) Journal of Antimicrobial Agents and Chemotherapy , vol.54 , pp. 266-268
    • Pandey, R.1    Khuller, G.K.2
  • 71
    • 70249116461 scopus 로고    scopus 로고
    • Nanoparticles in tuberculosis diagnosis, treatment and prevention: a hope for future
    • Mathuria, J. P. (2009). Nanoparticles in tuberculosis diagnosis, treatment and prevention: a hope for future. Digest Journal of Nanomaterials and Biostructures, 4(2), 309-312.
    • (2009) Digest Journal of Nanomaterials and Biostructures , vol.4 , Issue.2 , pp. 309-312
    • Mathuria, J.P.1
  • 72
    • 33750015512 scopus 로고    scopus 로고
    • Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo
    • Xenariou, S., Griesenbach, U., Ferrari, S., Dean, P., Schule, R. K., Cheng, S. H., et al. (2006). Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Therapy, 13, 1545-1552.
    • (2006) Gene Therapy , vol.13 , pp. 1545-1552
    • Xenariou, S.1    Griesenbach, U.2    Ferrari, S.3    Dean, P.4    Schule, R.K.5    Cheng, S.H.6
  • 73
    • 0347354994 scopus 로고    scopus 로고
    • Transfection of airway epithelium by stable PEGylated poly L-lysine DNA nano-particles in vivo
    • Ziardy, A. G., et al. (2003). Transfection of airway epithelium by stable PEGylated poly L-lysine DNA nano-particles in vivo. Molecular Therapy, 8, 936-947.
    • (2003) Molecular Therapy , vol.8 , pp. 936-947
    • Ziardy, A.G.1
  • 74
    • 19944398726 scopus 로고    scopus 로고
    • Compacted DNA nano-particles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution
    • Konstan, M. W., et al. (2004). Compacted DNA nano-particles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Human Gene Therapy, 15, 1255-1269.
    • (2004) Human Gene Therapy , vol.15 , pp. 1255-1269
    • Konstan, M.W.1
  • 75
    • 33845346100 scopus 로고    scopus 로고
    • Nanoparticles: health effects-pros and cons
    • Gwinn, M. R., & Vallyathan, V. (2006). Nanoparticles: health effects-pros and cons. Environmental Health Perspectives, 114(12), 1818-1825.
    • (2006) Environmental Health Perspectives , vol.114 , Issue.12 , pp. 1818-1825
    • Gwinn, M.R.1    Vallyathan, V.2
  • 76
    • 20644449754 scopus 로고    scopus 로고
    • Nano-toxicology: an emerging discipline evolving from studies of ultrafine particles
    • Oberdorster, G., Oberdorster, E., Oberdorster, J. (2005). Nano-toxicology: an emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspective, 113, 823-839.
    • (2005) Environmental Health Perspective , vol.113 , pp. 823-839
    • Oberdorster, G.1    Oberdorster, E.2    Oberdorster, J.3
  • 77
    • 17444377960 scopus 로고    scopus 로고
    • Antitubercular inhaled therapy: opportunities, progress and challenges
    • Pandey, R. (2005). Antitubercular inhaled therapy: opportunities, progress and challenges. Journal of Antimicrobial Chemotherapy, 55, 430.
    • (2005) Journal of Antimicrobial Chemotherapy , vol.55 , pp. 430
    • Pandey, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.